Replies to post #21780 on Shell Stocks; Reverse Mergers; Acquisitions; Zombi

[$hellKing]

Dr. Raouf Guirguis has been the Chief Executive Officer and President of Point of Care Nano-Technology, Inc., since February 26, 2015 and its Chief Financial Officer since October 22, 2015. Since 2011, Dr. Guirguis has been the President of Converting Biophile Laboratories, LLC. His involvement with the companies ranged from the conception of the business plan to technology packaging, mergers and acquisitions, and business development. From 2005 to 2010, he served as the President of Diplomatic Language Services, LLC. He has been a Director of Care Nano-Technology, Inc., since February 26, 2015. Dr. Guirguis served as Pathology Fellow, National Cancer Institute, NIH from 1984 to 1989 and was a Georgetown University Scholar from 1985 to 1988. He holds an M.D. as well as an M.S., in General Medical Practice from the University of Alexandria, Egypt. He holds an M.S. in Biomedical Engineering and a Ph.D. in Physiology and Biophysics from Georgetown University